Glomerular structural changes [48], combined with the low circulating adiponectin [49] and the glomerular permselectivity effect of angiotensin II [50], were appointed as contributing factors for the increased prevalence of albuminuria and subnephrotic proteinuria in patients with obesity [51]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.